ECSP045396A - Proceso para preparar derivados de 6-alquiliden penem - Google Patents

Proceso para preparar derivados de 6-alquiliden penem

Info

Publication number
ECSP045396A
ECSP045396A EC2004005396A ECSP045396A ECSP045396A EC SP045396 A ECSP045396 A EC SP045396A EC 2004005396 A EC2004005396 A EC 2004005396A EC SP045396 A ECSP045396 A EC SP045396A EC SP045396 A ECSP045396 A EC SP045396A
Authority
EC
Ecuador
Prior art keywords
penem
rent
prepare derivatives
derivatives
prepare
Prior art date
Application number
EC2004005396A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of ECSP045396A publication Critical patent/ECSP045396A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/88Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D499/881Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with a hydrogen atom or an unsubstituted hydrocarbon radical, attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/88Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

La presente invención provee un proceso para hacer compuestos de Fórmula (I), los cuales son útiles para el tratamiento de la infección bacterial o enfermedad.
EC2004005396A 2002-05-01 2004-10-29 Proceso para preparar derivados de 6-alquiliden penem ECSP045396A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US37704802P 2002-05-01 2002-05-01

Publications (1)

Publication Number Publication Date
ECSP045396A true ECSP045396A (es) 2005-01-03

Family

ID=29401435

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2004005396A ECSP045396A (es) 2002-05-01 2004-10-29 Proceso para preparar derivados de 6-alquiliden penem

Country Status (23)

Country Link
US (1) US20040053913A1 (es)
EP (1) EP1499620B1 (es)
JP (1) JP2005523937A (es)
KR (1) KR20050007369A (es)
CN (1) CN100516069C (es)
AR (1) AR039476A1 (es)
AT (1) ATE456569T1 (es)
AU (2) AU2003228773A1 (es)
BR (1) BR0309753A (es)
CA (1) CA2483533A1 (es)
CR (1) CR7512A (es)
DE (1) DE60331138D1 (es)
EC (1) ECSP045396A (es)
IL (1) IL164900A0 (es)
MX (1) MXPA04010661A (es)
NO (1) NO20044548L (es)
NZ (1) NZ536183A (es)
RU (1) RU2317297C2 (es)
SG (1) SG165159A1 (es)
TW (1) TW200403248A (es)
UA (1) UA78047C2 (es)
WO (1) WO2003093277A1 (es)
ZA (1) ZA200409687B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR039774A1 (es) * 2002-05-01 2005-03-02 Wyeth Corp 6-alquiliden-penems biciclicos como inhibidores de beta-lactamasas
US20040132708A1 (en) * 2002-05-01 2004-07-08 Wyeth Process for preparing 6-alkylidene penem derivatives
AR039475A1 (es) * 2002-05-01 2005-02-23 Wyeth Corp 6-alquiliden-penems triciclicos como inhibidores de beta-lactamasa
US7316917B2 (en) 2003-05-16 2008-01-08 Wyeth Holdings Corporation Production of bicyclic-heteroaryl-2-carboxylic acids by selective enzymatic hydrolysis of a mixture of positional esters
TW200716102A (en) * 2005-06-01 2007-05-01 Wyeth Corp Bicyclic 6-alkylidene-penems as class-D β -lactamases inhibitors
TW200716104A (en) * 2005-06-01 2007-05-01 Wyeth Corp Tricyclic 6-alkylidene-penems as class-D β -lactamases inhibitors
CA2615886A1 (en) * 2005-07-27 2007-02-08 Wyeth Bicyclic 6-alkylidene-penem beta-lactamase inhibitors and beta-lactam antibiotic combination: a broad spectrum antibiotic
BRPI0613928A2 (pt) * 2005-07-27 2011-02-15 Wyeth Corp método para o tratamento de uma infecção ou doença bacteriana; composição; produto; e uso de cefepima ou de um sal farmaceuticamente aceitável da mesma e um composto de fórmula i ou um sal farmaceuticamente aceitável ou éster hidrolisável in vivo do mesmo
GT200600380A (es) * 2005-08-24 2007-03-29 Proceso para la preparacion de inhibidores de beta-lactamasa
US20090018332A1 (en) * 2007-06-28 2009-01-15 Wyeth Processes For Preparing Bicyclic Oxazine Carboxaldehyde and Beta-Lactamase Inhibitors
US20100063023A1 (en) * 2008-09-10 2010-03-11 Wyeth Bicyclic and Tricyclic Substituted 6-Methylidene Carbapenems as Broad Spectrum Beta-Lactamase Inhibitors
CN102020615B (zh) * 2009-09-11 2012-08-29 中国中化股份有限公司 一种吗啉酮衍生物及其制备方法
CN102020658B (zh) * 2009-09-11 2012-05-23 中国中化股份有限公司 2-氯-6,8-二氢-5H-咪唑[2,1-c]-[1,4]噁嗪及其制备方法
US20110288063A1 (en) * 2010-05-19 2011-11-24 Naeja Pharmaceutical Inc. Novel fused bridged bicyclic heteroaryl substituted 6-alkylidene penems as potent beta-lactamase inhibitors
EA026931B9 (ru) 2012-09-25 2017-11-30 Байер Кропсайенс Аг Гербицидно и фунгицидно действующие 5-оксизамещенные 3-фенилизоксазолин-5-карбоксамиды и 5-оксизамещенные 3-фенилизоксазолин-5-тиоамиды или их соли

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4206067A (en) * 1978-10-02 1980-06-03 Chevron Research Company Thermally stabilized erosion-inhibited functional fluids containing perhalometal compounds and an organic base
GB8518416D0 (en) * 1985-07-22 1985-08-29 Beecham Group Plc Compounds
DE3752124T2 (de) * 1986-01-17 1998-03-26 Beecham Group Plc Verfahren zur Herstellung von Penem Derivaten und Zwischenprodukte zu dieser Herstellung
US4891369A (en) * 1986-12-03 1990-01-02 Taiho Pharmaceutical Company, Limited 2β-Substituted-methylpenicillanic acid derivatives, and salts and esters thereof
GB2210774B (en) * 1987-10-15 1991-06-12 Lui To Yan A curtain
US4977256A (en) * 1987-12-07 1990-12-11 Lederle (Japan), Ltd. Method of eliminating protective groups
GB8729613D0 (en) * 1987-12-18 1988-02-03 Beecham Group Plc Novel compounds
GB9222700D0 (en) * 1992-10-29 1992-12-09 Smithkline Beecham Plc Chemical compounds
MX9605149A (es) * 1994-04-25 1997-12-31 Smithkline Beecham Plc Formulaciones farmaceuticas que contienen una penema inhibidora de beta-lactamasa en combinacion con un antibiotico de beta-lactama y su uso en el tratamiento de infecciones bacterianas.
CN1334727A (zh) * 1998-10-15 2002-02-06 萨拉沃克梅迪切姆药品公司 治疗和预防结核病的方法和组合物
GB9928290D0 (en) * 1999-12-01 2000-01-26 Univ Belfast Process for preparing ambient temperature ionic liquids
AR039774A1 (es) * 2002-05-01 2005-03-02 Wyeth Corp 6-alquiliden-penems biciclicos como inhibidores de beta-lactamasas
US20040132708A1 (en) * 2002-05-01 2004-07-08 Wyeth Process for preparing 6-alkylidene penem derivatives
AR039475A1 (es) * 2002-05-01 2005-02-23 Wyeth Corp 6-alquiliden-penems triciclicos como inhibidores de beta-lactamasa
AR046041A1 (es) * 2003-10-03 2005-11-23 Aventis Pharma Inc Procedimiento para la preparacion de compuestos heterociclicos n-amino sustituidos

Also Published As

Publication number Publication date
RU2004135088A (ru) 2006-01-20
UA78047C2 (en) 2007-02-15
CR7512A (es) 2005-01-05
AU2010200930A1 (en) 2010-04-01
CA2483533A1 (en) 2003-11-13
ZA200409687B (en) 2009-02-25
RU2317297C2 (ru) 2008-02-20
KR20050007369A (ko) 2005-01-17
AU2003228773A1 (en) 2003-11-17
JP2005523937A (ja) 2005-08-11
SG165159A1 (en) 2010-10-28
MXPA04010661A (es) 2005-01-25
NO20044548L (no) 2004-11-26
ATE456569T1 (de) 2010-02-15
DE60331138D1 (de) 2010-03-18
AR039476A1 (es) 2005-02-23
BR0309753A (pt) 2005-03-08
TW200403248A (en) 2004-03-01
EP1499620A1 (en) 2005-01-26
US20040053913A1 (en) 2004-03-18
CN1649881A (zh) 2005-08-03
EP1499620B1 (en) 2010-01-27
CN100516069C (zh) 2009-07-22
NZ536183A (en) 2006-07-28
WO2003093277A1 (en) 2003-11-13
IL164900A0 (en) 2005-12-18

Similar Documents

Publication Publication Date Title
ECSP045396A (es) Proceso para preparar derivados de 6-alquiliden penem
GT200300292A (es) Derivados de pirimidina para el tratamiento de crecimiento celular anormal
TW200510333A (en) Benzimidazole compounds
SV2005001973A (es) Quinolinas utiles en el tratamiento de enfermedades cardiovasculares ref. wyth0090-504 (am101500)
ATE433447T1 (de) Pyrimiidinverbindungen
PA8571001A1 (es) 2-(2,6-diclorofenil)-diarilimidazoles
CY1119077T1 (el) Παραγωγα πυραζολυλαμινοπυριδινης χρησιμα ως αναστολεις κινασων
ECSP066447A (es) Derivados de isoquinolina 1,4-disustituida como inhibidores raf-quinasa útiles para el tratamiento de enfermedades proliferativas
SV2006002187A (es) Indazoles utiles para tratamientos de enfermedades cardiovasculares ref.wyth0089-504(am101590)
CY1107956T1 (el) Χρηση υποκατεστημενων 2-αμινοτετραλινιων για την προληπτικη αντιμετωπιση της νοσου του παρκινσον
UY28473A1 (es) Nuevos compuestos
DE602004014347D1 (de) Chinazolin-derivate als tgf-beta-inhibitoren
HRP20090281T1 (hr) 1,2,3,4-tetrasubstituirani indol za liječenje respiratornih bolesti
UY28333A1 (es) Inhibidores de caspasa y sus usos.
EA200600621A1 (ru) Производные тетрагидронафталина, способ их получения и их применение в качестве противовоспалительных средств
ES2186550B2 (es) Nuevos derivados de oxazolidinonas como antibacterianos.
NO20044526L (no) Hemisterlinderivater og anvendelser derav
NO20055632L (no) Aromatiske oksyfenyl- og aromatiske sulfanylfenylderivater
CY1113197T1 (el) Παραγωγα 5-υδροξυμεθυλ- οξαζολιδιν-2-ονης για την αντιμετωπιση βακτηριακων νοσων του εντερου
ECSP045397A (es) 6-ALQUILIDEN-PENEMS BICÍCLICOS COMO INHIBIDORES DE LAS b-LACTAMASAS
PT1606288E (pt) Derivados de benzenossulfonamida, processo para a sua preparação e a sua utilização para tratamento da dor
UY27451A1 (es) 2,5-diamidoindoles sustituidos y su utilización
ECSP055693A (es) Proceso para la síntesis de intermediarios útiles para la síntesis de inhibidores de la tubulina
ECSP024377A (es) Derivados de benzo (g) quinolina
ECSP045405A (es) Penems 6-alquiliden heterotriciclil como inhibidores de la beta lactamasa